Abbreviations used in this paper: coIP, coimmunoprecipitation; DIC, differential interference contrast; ELC, essential light chain; RLC, regulatory light chain; SC, synthetic complete.

Introduction
============

Cytokinesis is the last event in the cell division cycle and likely occurs by the contraction of a cortical actomyosin ring, which consists of type II myosin and F-actin. This contraction mechanism must be coordinated with membrane deposition at the cleavage site to ensure efficient cytokinesis and cell separation. Analysis of cytokinesis in the yeasts *Saccharomyces cerevisiae* and *Schizosaccharomyces pombe* has demonstrated that the basic mechanisms underlying cytokinesis are conserved between yeast and animal cells.

Each heavy chain of the type II myosin binds to two light chains, an essential light chain (ELC) proximal to the myosin head and a regulatory light chain (RLC) downstream of the ELC. These interactions are mediated by two tandem IQ motifs in the heavy chain. The ELC in *Dictyostelium discoideum* is required for cytokinesis and may regulate the actin-activated ATPase of the heavy chain ([@bib32]), but it is not clear whether the role of the ELC in cytokinesis is performed primarily through its regulation of the heavy chain or another IQ-containing protein. In *S. pombe*, Cdc4p is the ELC for the two type II myosins. Cdc4p also interacts with a type V myosin, Myo51p, and an IQGAP-related protein, Rng2p, and it appears that at least one essential function of Cdc4p is mediated through these proteins as deletion of the IQ domains of the essential type II myosin, Myo2, does not suppress the defects caused by mutations in Cdc4p ([@bib10]). The major role of RLC may be to regulate the actin-activated Mg^2+^-ATPase activity and stability of myosin filaments ([@bib35]; [@bib45]; [@bib26]). Studies in *D. discoideum* and *S. pombe* suggest the binding of RLC to the heavy chain relieves an auto-inhibitory function of the RLC binding site as deletion of the relevant IQ site on the heavy chain suppresses defects associated with mutations in the RLC ([@bib47]; [@bib28]). Myosin II molecules purified from RLC null cells in *D. discoideum* assemble into thick filaments with normal kinetics, but display a defect in filament disassembly in vitro ([@bib7]). This defect has not been confirmed by in vivo studies.

Unlike the case in most animal cells and *S. pombe*, deletion of *MYO1*, which encodes the only type II myosin in *S. cerevisiae*, causes a defect in cytokinesis and cell separation, but not lethality, suggesting that actomyosin ring-independent mechanisms can carry out cytokinesis, albeit less efficiently ([@bib3]; [@bib48]; [@bib43]). Further studies suggest that this alternative mechanism may involve septum formation and/or targeted secretion. In contrast to *MYO1*, deletion of *IQG1/CYK1*, which encodes the only IQGAP in *S. cerevisiae*, or deletion of *MLC1*, which encodes a light chain for the type V myosin Myo2p and for Iqg1p, causes lethality with cells arrested in cytokinesis ([@bib11]; [@bib41]; [@bib22]; [@bib36]). Mlc1p is required for the recruitment of Iqg1p to the bud neck ([@bib36]), which, in turn, is required for actin ring formation ([@bib11]; [@bib22]). Because Iqg1p and Mlc1p are essential, they must play a role in the alternative mechanism in cytokinesis in addition to a role in actomyosin ring function.

Myo1p in *S. cerevisiae* contains two noncanonical IQ motifs. The light chains for Myo1p have not previously been identified, although Mlc1p is coimmunoprecipitated with Myo1p ([@bib4]). We demonstrate here that Mlc1p is the ELC for Myo1p. However, binding of Mlc1p to Myo1p does not appear to play a major role in regulating Myo1p, but instead Mlc1p interacts with Myo1p, Iqg1p, and Myo2p to regulate actin ring formation and targeted secretion. In addition, we identify and demonstrate that Mlc2p is the RLC for Myo1p and that Mlc2p most likely plays a role in the disassembly of the Myo1p ring in vivo.

Results
=======

Identification of Mlc2p
-----------------------

To identify the light chains for Myo1p, the head domain of Myo1p containing two putative IQ motifs ([Fig. 1](#fig1){ref-type="fig"} A) was used in a two-hybrid screen against the yeast ORF-Gal4p activation domain fusion array to identify interacting proteins. Only one protein, encoded by *YPR188C,* was a positive interactor in this screen ([Fig. 1](#fig1){ref-type="fig"} B). For reasons described later, *YPR188C* is named *MLC2* (*Myo1p light chain 2*). Mlc2p consists of 163 amino acids and displays significant sequence homology to calmodulin (or myosin light chain)-related proteins, with identities in the range of 25--30% and similarities ∼50% ([Fig. 1](#fig1){ref-type="fig"} C). Like other light chains, Mlc2p contains an EF hand (amino acids 28--40) and a serine at residue 6 that corresponds to one of the activating phosphorylation sites, Ser19, in the human type II myosin RLC ([@bib46]; [Fig. 1](#fig1){ref-type="fig"} C; MRLC2).

![**Identification of Mlc2p.** (A) The positions and sequences of the IQ1 and IQ2 motifs in Myo1p. The bold letters indicate generally conserved sequences in IQ motifs of type II myosins. (B) Myo1p-N (the head domain) interacts with Mlc2p by two-hybrid assay. Strain PJ69-4α carrying the bait plasmid pOBD (DBD vector) or pOBD-MYO1-N (DBD-MYO1-N) was crossed with strain PJ69-4**a** carrying the prey plasmid pOAD alone or carrying one of its derivatives that contain one of the six calmodulin-related genes in *S. cerevisiae*, *MLC2*, *MLC1*, *CMD1*, *FRQ1*, *CDC31*, and *CNB1*. Diploids from the mating reactions were selected on SC-Trp-Leu and then replica-plated onto SC-His for detecting positive interactions. (C) Alignment of Mlc2p with other myosin II RLCs. The putative phosphorylation site, Ser6, is indicated by an asterisk and the EF hand is marked with a top line. Mlc2p (Scer) from *S. cerevisiae*; MLC (Scas) from *S. castelli* (Contig 631.6, <http://genome-www4.stanford.edu/cgi-bin/FUNGI/showAlign?locus=YPR188C&source=WashU>); Rlc1p (Sp) from *S. pombe*; and MRLC2 (Hs) from *Homo sapiens*. Sequences are aligned with MacVector software.](200401040f1){#fig1}

Mlc1p, a light chain for the type V myosin Myo2p ([@bib41]) and also for the IQGAP-like protein Iqg1p/Cyk1p ([@bib36]), can be coimmunoprecipitated with Myo1p ([@bib4]), suggesting that Mlc1p might also be a light chain for Myo1p. However, an interaction between Mlc1p and the Myo1p head ([Fig. 1](#fig1){ref-type="fig"} B) was not detected by two-hybrid assays, even in the absence of Mlc2p (not depicted). Similarly, no interaction was detected between the Myo1p head and other calmodulin-related proteins.

Mlc2p localizes to the bud neck in a Myo1p-dependent manner
-----------------------------------------------------------

If Mlc2p were a light chain for Myo1p, Mlc2p should show similarity in its localization to Myo1p. Indeed, Mlc2p is the only known protein that displays an identical localization profile in the cell cycle as Myo1p. Mlc2p first localized to the presumptive bud site as a cortical ring ([Fig. 2](#fig2){ref-type="fig"} A, cell 1). Once the bud emerged, Mlc2p formed a ring at the bud neck ([Fig. 2](#fig2){ref-type="fig"} A, cells 2 and 3). The Mlc2p ring maintained its diameter at the neck until late anaphase when the Mlc2p ring started to contract. The contraction process, which took 8--10 min ([Fig. 2](#fig2){ref-type="fig"} B, bottom), was followed closely by the centripetal septum formation ([Fig. 2](#fig2){ref-type="fig"} B, top), a behavior very similar to that of Myo1p ([@bib3]; [@bib22]). The neck localization of Mlc2p was completely abolished in *myo1*Δ cells ([Fig. 2](#fig2){ref-type="fig"} C, middle). In contrast, the neck localization of Myo1p was not affected by deletion of *MLC2* (analyzed in detail later; [Fig. 2](#fig2){ref-type="fig"} C, right). These results are consistent with the possibility that Mlc2p is a light chain for Myo1p and Mlc2p localizes to the neck through an interaction with Myo1p.

![**Localization pf Mlc2p to the bud neck and its dependency on Myo1p.** (A) Localization of Mlc2p in the cell cycle. Cells of YEF2474 (*MLC2-GFP/ MLC2-GFP*) grown exponentially in YM-P were fixed with formaldehyde and visualized by DIC and fluorescence microscopy. (B) Contraction of Mlc2p-GFP ring during late anaphase of the cell cycle. Cells of YEF2474 grown exponentially in SC medium were analyzed by time-lapse microscopy at 20°C. (C) Localization of Mlc2p to the bud neck depends on Myo1p. Localization of Mlc2p in YEF2565 (*myo1*Δ*/myo1*Δ *MLC2-GFP/MLC2-GFP*) with (left) or without (middle) the plasmid YCp50-MYO1 and localization of Myo1p in YEF2616 (*mlc2*Δ*/mlc2*Δ *MYO1-GFP/MYO1-GFP*; right) were examined after streaking the strains onto YPD plates and incubating the plates at 24°C for 12--16 h.](200401040f2){#fig2}

Mlc2p binds to IQ2 of Myo1p and thus defines an RLC for Myo1p
-------------------------------------------------------------

To determine the binding site of Mlc2p on Myo1p, we generated Myo1p mutants with a precise deletion of IQ1 (amino acids 795--815), IQ2 (amino acids 827--850), or both (amino acids 795--850; [Fig. 3](#fig3){ref-type="fig"} A). All these variants were under the *MYO1* promoter control and were tagged with GFP immediately after their start codon. Centromere-based plasmids carrying these *myo1* alleles along with control plasmids were transformed into a *myo1*Δ *MLC2:MYC* strain, individually, for coimmunoprecipitation (coIP) experiments. As shown in [Fig. 3](#fig3){ref-type="fig"} B, MYC-tagged Mlc2p coimmunoprecipitated effectively with GFP-tagged full-length Myo1p, Myo1p without IQ1 (IQ1Δ), and Myo1p with a point mutation at residue 806 \[R806A (IQ1)\] that changes the highly conserved arginine among all known type II myosins to alanine ([Fig. 1](#fig1){ref-type="fig"} A). In contrast, the interaction between Mlc2p and Myo1p was abolished completely when IQ2 was deleted ([Fig. 3](#fig3){ref-type="fig"} B). As expected, Mlc2p did not interact with Myo1p deleted for both IQ1 and IQ2 ([Fig. 3](#fig3){ref-type="fig"} B).

![**Mlc2p binds to IQ2 of Myo1p exclusively.** (A) Diagram of IQ mutants of Myo1p. Asterisk indicates R806A change in IQ1. (B) Mlc2p binds to Myo1p through IQ2. Strain YEF3175 (**a** *myo1*Δ*::Kan MLC2:MYC*) was transformed individually with plasmid pRS316NoNot (Vector), pRS316-MYO1 (untagged Myo1p), and pRS316-N-MYO1-GFP or its IQ mutant derivatives. Transformants were grown exponentially in SC-Ura media at 24°C and processed for coIP experiments. Mlc2p-MYC: Mlc2p-MYC in the immunoprecipitates brought down by anti-MYC--conjugated agarose beads from different cell lysates; Myo1p-GFP-input: Myo1p-GFP in different cell lysates before immunoprecipitation; Myo1p-GFP-bound: Myo1p-GFP in the immunoprecipitates from different cell lysates. White lines indicate that intervening lanes have been spliced out. (C) Mlc2p fails to localize to the bud neck in cells carrying *myo1-IQ2*Δ. YEF2603 (*myo1*Δ*/myo1*Δ *MLC2:GFP/MLC2:GFP*) was transformed individually with plasmid pRS316-N-MYO1-R806A-GFP (R806A), pRS316-N-MYO1-IQ1Δ-GFP (IQ1Δ), pRS316-N-MYO1-IQ2Δ-GFP (IQ2Δ), or pRS316-N-MYO1-(IQ1Δ+IQ2Δ)-GFP (IQ1Δ+IQ2Δ). Transformants were grown exponentially in SC-Ura media, fixed with formaldehyde, and observed with DIC and fluorescence microscopy.](200401040f3){#fig3}

The coIP results correlate perfectly with the localization studies of Mlc2p in various IQ mutants of Myo1p. Mlc2p localized normally in cells containing Myo1p-R806A or Myo1p-IQ1Δ as the sole source of Myo1p ([Fig. 3](#fig3){ref-type="fig"} C). In contrast, the neck localization of Mlc2p was abolished completely in cells containing Myo1p-IQ2Δ or Myo1p-(IQ1Δ+IQ2Δ) ([Fig. 3](#fig3){ref-type="fig"} C), even though these mutant forms of *MYO1* were expressed at a similar level as the corresponding wild type, and the Myo1p mutants themselves localized normally to the bud neck ([Fig. 3](#fig3){ref-type="fig"} B and not depicted). This result is similar to those seen in *S. pombe* where deletion of the RLC binding site on type II myosins abolishes the localization of RLC to the division site ([@bib28]). Together, the coIP results and the localization studies indicate that Mlc2p binds to Myo1p exclusively through IQ2. Based on the fact that RLCs of all known type II myosins bind to their heavy chains through IQ2, Mlc2p is likely a bona fide RLC for Myo1p.

Mlc2p plays a role in the disassembly of the Myo1p ring in vivo
---------------------------------------------------------------

Surprisingly, deletion of *MLC2* did not produce any obvious defects in growth rate, cytokinesis, and cell separation at temperatures ranging from 18 to 37°C on plates containing synthetic complete (SC) media or YPD media in the presence or absence of 1 M sorbitol or 0.9 M KCl, except that occasionally *mlc2*Δ cells formed cell clusters containing more than three cell bodies (unpublished data). Consistent with the hypothesis that Mlc2p functions through Myo1p, deletion of *MLC2* and *MYO1* together did not produce any additive effect on cytokinesis and cell separation. In addition, deletion of *MLC2* together with each of the known cytokinesis genes including *BNI1*, *BNR1*, *HOF1*, and *CYK3* did not significantly enhance the phenotypes of the single mutants (unpublished data). Furthermore, screens against the ordered array of yeast deletion mutants at 30 and 37°C failed to identify any mutants that displayed synthetic--lethal or synthetic--sick interactions with *mlc2*Δ cells. These data suggest that there might be multiple genes sharing a role with Mlc2p in cytokinesis; or more likely, that Mlc2p plays a subtle role in cytokinesis under laboratory conditions.

Upon detailed analyses, we found that the rate of Myo1p ring contraction in *mlc2*Δ diploid cells was approximately the same as that of an isogenic wild-type strain, but that there was a defect in ring disassembly. In wild-type cells at 20°C, the Myo1p "dot" disappeared within 1 min at the end of contraction (*n* = 7). However, ∼46% of the *mlc2*Δ diploid cells (*n* = 13) showed a 2 to 8 min delay in the disassembly of the Myo1p dot at the end of its contraction at 20°C. We also performed time-lapse analyses on the same strains at 37°C. Unfortunately, the Myo1p-GFP signal at 37°C was not strong enough to produce interpretable time-lapse series. To pursue the mutant phenotype further, we reasoned that if the Myo1p ring were enlarged, the effect of *mlc2* deletion on the disassembly of the Myo1p dot might be enhanced. Therefore, we constructed a tetraploid strain homozygous for *MYO1-GFP* and *mlc2*Δ. The diameter of the bud neck of tetraploid cells was increased ∼27% over that of isogenic diploid cells (*n* = 40; the width and the length of the tetraploid cells were increased ∼22% and ∼28% over those of the diploid cells, respectively). At 20°C, ∼50% of the *mlc2*Δ tetraploid cells (*n* = 10) showed persistence of the Myo1p dot for at least 2--8 min in comparison to ∼11% of the control cells (*n* = 9). In contrast to the diploid cells, the Myo1p-GFP signal at 37°C in tetraploid cells was strong enough to permit time-lapse analyses. ∼80% of the *mlc2*Δ tetraploid cells (*n* = 10; [Fig. 4](#fig4){ref-type="fig"} B) showed a delay in the disassembly of the Myo1p dot in comparison to 0% of the control cells (*n* = 10; [Fig. 4](#fig4){ref-type="fig"} A). The Myo1p-GFP contraction rates for these tetraploid cells at 37°C are similar for wild-type and for *mlc2*Δ cells (0.344 ± 0.014 μm/min, *n* = 6, and 0.347 ± 0.044 μm/min, *n* = 5, respectively). These data strongly suggest that Mlc2p might regulate the disassembly of Myo1p ring, at least at the end of its contraction.

![**Myo1p ring disassembly is defective in *mlc2***Δ **cells.** Time-lapse analyses of tetraploid wild-type (YEF3323; A) and *mlc2*Δ (YEF3324; B) cells carrying *MYO1-GFP* by DIC and fluorescence microscopy at 37°C.](200401040f4){#fig4}

Because Mlc2p binds exclusively to IQ2 of Myo1p, we wondered if deletion of IQ2 would cause a similar defect in Myo1p disassembly. We performed time-lapse analyses on *myo1*Δ diploid cells carrying plasmid pRS316-MYO1-IQ2Δ-GFP, a centromeric plasmid carrying the *myo1-IQ2*Δ allele. Perhaps due to a slightly higher expression of Myo1p-IQ2Δ from the plasmid, this strain allowed time-lapse analyses at 37°C. Myo1p ring contraction and the disassembly of Myo1p dot occurred normally in ∼80% of cells carrying Myo1p-IQ2Δ as the sole source of Myo1p (*n* = 5) in comparison to 100% of the control cells carrying wild-type *MYO1* (*n* = 5). These results suggest that IQ2 might be inhibitory to the disassembly of the Myo1p dot and that Mlc2p binding to IQ2 is normally involved in relieving this inhibitory effect, similar to what has been observed in *S. pombe* ([@bib28]) and *D. discoideum* ([@bib47]).

Mlc1p is an ELC for Myo1p but deletion of its binding site on Myo1p does not appear to affect Myo1p function
------------------------------------------------------------------------------------------------------------

Mlc1p is known to coimmunoprecipitate with Myo1p ([@bib4]), suggesting that it might be a light chain for Myo1p. To examine this possibility, we mapped the binding site of Mlc1p on Myo1p by coIP experiments with the various IQ mutants of Myo1p. In contrast to Mlc2p, Mlc1p bound to Myo1p-IQ2Δ very efficiently, but failed to bind to Myo1p-IQ1Δ or Myo1p-(IQ1Δ+IQ2Δ) ([Fig. 5](#fig5){ref-type="fig"} A). These data indicate that Mlc1p binds to Myo1p through IQ1 and thus likely defines an "ELC" for Myo1p.

![**Mlc1p--Myo1p interaction is disposable for Myo1p function.** (A) Mlc1p binds to Myo1p through IQ1. Strain YEF3176 (**a** *myo1*Δ*::Kan MLC1:3HA*) was transformed individually with plasmid pRS316-N-MYO1-GFP or its IQ mutant derivatives. Transformants were used for coIP experiments as shown in [Fig. 3](#fig3){ref-type="fig"}. Mlc1p-HA: Mlc1p-HA in the immunoprecipitates brought down by anti-HA--conjugated agarose beads from different cell lysates; Myo1p-GFP-input and Myo1p-GFP-bound: as in [Fig. 3](#fig3){ref-type="fig"}. (B) Myo1p deficient in Mlc1p binding contracts normally. Time-lapse analysis of a cell from YEF1820 (*myo1*Δ*/myo1*Δ) carrying plasmid pRS316-N-MYO1-(IQ1Δ+IQ2Δ)-GFP at 20°C.](200401040f5){#fig5}

Interestingly, deletion of IQ1 alone or together with IQ2 did not affect the rate of the Myo1p ring contraction (*n* = 8) or the disassembly of the Myo1p dot at the end of Myo1p contraction (only one out of eight cells showed a slight delay in the disassembly of the Myo1p dot, similar to the behavior of Myo1p-IQ2Δ cells described previously; [Fig. 5](#fig5){ref-type="fig"} B). These data suggest that binding of Mlc1p to Myo1p does not appear to play a major role in regulating Myo1p function and that the neck region of Myo1p including both IQ motifs is not essential for Myo1p function. A similar relationship between the type II myosins and their ELC Cdc4p has been observed in the fission yeast *S. pombe* ([@bib10]).

Mlc1p targets to the bud neck in the absence of its interactions with Myo1p and Myo2p
-------------------------------------------------------------------------------------

Because Mlc1p localizes to the bud neck and plays an essential role in cytokinesis ([@bib41]; [@bib36]; [@bib49]), understanding the mechanisms underlying its neck localization might facilitate understanding its function in cytokinesis in general. Previous studies showed that the neck localization of Mlc1p occurs in strains deleted for Myo1p and in strains deleted for the IQ motifs of Myo2p ([@bib4]; [@bib36]; [@bib49]). In addition, although Mlc1p binds to Iqg1p, Mlc1p localization to the bud neck occurs before and independently of Iqg1p ([@bib4]). In contrast, bud tip localization of Mlc1p has been demonstrated to largely depend on its interaction with the IQ motifs of Myo2p ([@bib36]). Some of these results are confirmed here ([Fig. 6](#fig6){ref-type="fig"}). We hypothesized that the IQ motifs in Myo1p and Myo2 might function redundantly in recruiting Mlc1p to the bud neck. Therefore, we examined whether or not simultaneous elimination of Mlc1p interactions with Myo1p and Myo2p would abolish the localization of Mlc1p to the bud neck. If so, this might cause cells to arrest at cytokinesis and/or cell separation, which would explain the essential role of Mlc1p in cytokinesis. However, the *myo1*Δ *myo2IQ6*Δ double mutant was viable and Mlc1p localized to the bud neck in the double mutant, albeit less efficiently than in either single mutant ([Fig. 6](#fig6){ref-type="fig"} A). These results suggest that some Mlc1p molecules can localize to the bud neck independently of their interaction with either Myo1p or Myo2p. Surprisingly, the percentage of cells showing bud tip localization of Mlc1p in the *myo1*Δ *myo2IQ6*Δ double mutant was increased in comparison to the *myo2IQ6*Δ single mutant ([Fig. 6](#fig6){ref-type="fig"} A), suggesting that Myo1p might normally trap some Mlc1p molecules at the bud neck and prevent them from reaching the bud tip. The tip, but not the neck, localization of Mlc1p was completely eliminated in the *myo1*Δ *myo2IQ6*Δ *myo4*Δ triple mutant ([Fig. 6](#fig6){ref-type="fig"} A). Because budding was normal in the triple mutant, which presumably reflects normal targeting of secretory vesicles to the daughter cell, these results suggest that Mlc1p is normally targeted to the bud tip solely through its association with the two type V myosins, Myo2p and Myo4p, which have been shown to play a similar role in the bud tip localization of calmodulin ([@bib41]). These results also suggest that Mlc1p is not directly associated with secretory vesicles in contrast to a recent suggestion ([@bib49]).

![**Mlc1p localization in different mutants.** (A) Strains carrying pUG34-MLC1 were grown exponentially in SC-His media at 24°C and fixed for 10 min with 3.7% formaldehyde before visualization of GFP-tagged Mlc1p and DNA by fluorescence microscopy. Wild type, SSC1; *myo1*Δ, SSC350; *myo2IQ6*Δ, RSY21; *myo1*Δ *myo2IQ6*Δ, YEF3380; *myo4*Δ, YJL126; and *myo1*Δ *myo2IQ6*Δ *myo4*Δ, YJL114A. Class I, small-budded cells with a single nucleus. Class II, large-budded cells with a single nucleus. Class III, large-budded cells with two separated nuclei. (B) Indicated strains carrying pUG34-MLC1 were grown and processed for visualization of GFP-tagged Mlc1p as in A except some strains were shifted to 35 or 37°C for 5 or 30 min before sample collection. Wild type, SEY6210; *sec18-1*, SEY5188; *sec2-41*, JGY28B; and *cdc12-6*, M-17. (Class IV) Due to the strong influence on bud size and shape by secretory and septin mutants, budded cells (from small to large buds) with a single nucleus were grouped together and counted for the tip localization of Mlc1p. Class V was as Class III in A. At least 50 cells were counted for each sample.](200401040f6){#fig6}

What targets Mlc1p to the bud neck in the absence of its interactions with Myo1p, Myo2p, and Myo4p? Previous studies suggest that intact secretory pathway and septins may be involved in the bud neck localization of Mlc1p ([@bib4]; [@bib36]; [@bib49]). However, a previous work does not distinguish tip localization of Mlc1p from its neck localization in scoring the percentage of cells with a polarized Mlc1p signal ([@bib49]). The role of septins in targeting Mlc1p to the bud neck remains controversial. One paper ([@bib36]) indicates that the neck localization of Mlc1p depends on septins before anaphase, but is independent of the septins in cells with separated nuclei (late anaphase or telophase). Another paper indicates that the neck localization of Mlc1p depends on septins for the entire population of cells ([@bib4]). For these reasons, we reexamined the role of secretory pathway and the septins in the neck localization of Mlc1p. Our work showed that the neck localization of Mlc1p was largely unaffected by *sec18-1*, which blocks vesicle fusion at all stages of the secretory pathway or by *sec2-41* and *sec4-8*, which block secretion from the Golgi to plasma membrane ([Fig. 6](#fig6){ref-type="fig"} B). However, the bud tip localization of Mlc1p in these mutants was severely affected ([Fig. 6](#fig6){ref-type="fig"} B), suggesting that the *sec* mutations demonstrated the expected defect. Further, these data suggest that the neck localization of Mlc1p is independent of the secretory pathway, which is consistent with the conclusion reached with the *myo1*Δ *myo2IQ6*Δ *myo4*Δ triple mutant. Our work also showed that the neck localization of Mlc1p strongly depended on the septins, as only 2% of the budded cells with a single nucleus and 11.1% of cells with separated nuclei had Mlc1p at the bud neck after shifting the temperature-sensitive septin mutant, *cdc12-6*, to 37°C for 30 min ([Fig. 6](#fig6){ref-type="fig"} B). This result is in good agreement with one of the previous studies ([@bib4]).

In summary, there are at least three ways by which Mlc1p is targeted to the bud neck: by interacting with Myo1p or Myo2p directly and by interacting with the septins through an undefined mechanism.

Specific alleles of MLC1 reveal the functions of different Mlc1p interactions
-----------------------------------------------------------------------------

In a screen for mutations that displayed synthetic--lethal interactions with the deletion of *HOF1*, a gene involved in coupling actomyosin-ring function to septum formation (details of the screen will be described elsewhere; [@bib18]; [@bib23]; [@bib48]), we identified two mutant alleles of *MLC1*, which contain a single point mutation that causes either a glycine-to-aspartic acid change at residue 114 (G114D; *mlc1-11*) or a glycine-to-glutamic acid change at residue 135 (G135E; *mlc1-93*). Both changes occurred on amino acids that are highly conserved among the calmodulin (or light chain) superfamily ([Fig. 7](#fig7){ref-type="fig"} A). The *mlc1-11* cells were temperature-sensitive for growth (unpublished data) and showed a severe defect in cytokinesis even at 24°C, as the undivided *mlc1-11* cells still shared a cytoplasm indicated by the decoration of the plasma membrane by GFP-tagged Ras2p ([Fig. 7, B and C](#fig7){ref-type="fig"}). In contrast, the *mlc1-93* cells did not show any obvious defect in cytokinesis at temperatures ranging from 20 to 37°C ([Fig. 7](#fig7){ref-type="fig"} B and not depicted). To determine the molecular basis for the behavior of the *mlc1* mutant alleles, we did the following experiments. First, we determined the localization of the *mlc1* mutant proteins and their interaction with Myo2p. We found that the protein encoded by *mlc1-11* failed to localize efficiently to the presumptive bud site and to the bud tip ([Fig. 7](#fig7){ref-type="fig"} D), which is very similar to the localization of wild-type Mlc1p in a *myo2-IQ6*Δ strain ([@bib36]; [Fig. 6](#fig6){ref-type="fig"} and [Fig. 7](#fig7){ref-type="fig"} D). These data suggest that mlc1-11p may be defective in interaction with Myo2p, which was confirmed by coIP experiments ([Fig. 8](#fig8){ref-type="fig"} A). We also found that mlc1-11p localized to the bud tip less efficiently than wild-type Mlc1p in *myo2-IQ6*Δ cells ([Fig. 7](#fig7){ref-type="fig"} D, asterisks), suggesting that there must be another mechanism for targeting Mlc1p to the bud tip independently of the IQ motifs of Myo2p, in which mlc1-11p is deficient. This conclusion is supported by the fact that the bud tip localization of Mlc1p also depends on Myo4p ([Fig. 6](#fig6){ref-type="fig"} A). However, the localization of mlc1-11p to the bud neck was similar to that of the wild-type Mlc1p ([Fig. 7](#fig7){ref-type="fig"} D). Previous analysis indicates that the neck localization of Mlc1p largely depends on septin function, although a direct interaction has not been demonstrated (see previous section; [@bib4]; [@bib36]). In contrast to mlc1-11p, mlc1-93p localized normally to the incipient bud site, the bud tip, and the bud neck ([Fig. 7](#fig7){ref-type="fig"} D) and interacted normally with Myo2p ([Fig. 8](#fig8){ref-type="fig"} A). Next, we determined the effect of the *mlc1* mutations on the neck localization of Iqg1p, which depends on Mlc1p ([@bib36]). Iqg1p completely failed to localize to the bud neck in *mlc1-11* cells, indicating a defect in the Iqg1p--Mlc1p interaction, which was again confirmed by coIP experiments ([Fig. 8](#fig8){ref-type="fig"} B). In contrast, Iqg1p was able to localize in *mlc1-93* cells, albeit less efficiently ([Fig. 7](#fig7){ref-type="fig"} B). CoIP experiments showed that mlc1-93p interacted with Iqg1p to a similar extent as the wild-type Mlc1p did ([Fig. 8](#fig8){ref-type="fig"} B). Finally, we determined the interaction between the mlc1 mutant proteins with Myo1p. Both mlc1-11p and mlc1-93p displayed a similar reduced interaction with Myo1p ([Fig. 8](#fig8){ref-type="fig"} C).

![**Properties of *mlc1* alleles.** (A) Sequence alignment of Mlc1p with other calmodulin-related molecules. Mlc1p (Sc), Mlc1p in *S. cerevisiae*; Cdc4p (Sp), the ELC for type II myosins in *S. pombe*; Cmd1p (Sc), calmodulin in *S. cerevisiae*; and Calm1 (Hs), calmodulin 1 in *H. sapiens* (gi:31377794). (asterisks) Positions of the indicated mutations. (B) The effects of *mlc1* mutations on cytokinesis and Iqg1p localization. "Abnormal cytokinesis" is defined as cells with four or more connected cell bodies. At least 200 cells were scored for each strain. *MLC1:* wild type, YEF473A; *mlc1-11*: Y5005-8D, and *mlc1-93*: Y5119-20A. For Iqg1p localization, anaphase cells with two separated two nuclei from the indicated strains carrying the plasmid pUG35-IQG1 that contains *GFP-IQG1* were counted for the neck localization of Iqg1p. At least 50 cells were counted for each strain. (C) *mlc1-11* cells display cytokinesis defect at 24°C. Strain Y5005-8D (*mlc1-11*) carrying plasmid pRS315-GFP-RAS2 was grown exponentially in liquid SC-Leu media at 24°C before the visualization of GFP-tagged Ras2p by fluorescence microscopy. (D) *mlc1-11* is defective in bud tip localization. Plasmid pUG34 carrying wild-type *MLC1* or *mlc1-11* or *mlc1-93* was transformed into YEF473A and RSY21. Transformants were grown exponentially in SC-His media at 30°C. Cells were fixed with formaldehyde, and GFP-tagged Mlc1p and DNA were visualized by fluorescence microscopy. Asterisks highlight the low percentage of *myo2-IQ6*Δ cells with the bud tip localization of mlc1-11p.](200401040f7){#fig7}

![**The interactions of mlc1 mutant proteins with Myo2p, Iqg1p, and Myo1p.** (A) Myo2p-MYC was precipitated with anti-MYC-agarose beads from cell lysates of strains YJL176A (*MYO1:HA MYO2:MYC*) carrying pUG34 (vector), pUG34-MLC1 (Mlc1p), pUG34-MLC1-93 (mlc1-93p), or pUG34-MLC1-11 (mlc1-11p), respectively. Myo2p-MYC, Mlc1p-GFP, and its derivatives in the bound and in the input fractions were detected by Western-blot analysis with antibodies against MYC or GFP as indicated in A. (B) As in A except that strain YJL175A (*myo1*Δ *IQG1:HA MYO2:MYC*) carrying the different plasmids and the anti-HA-agarose beads were used to do the pull down. (C) As in A except that anti-HA-agarose beads were used to do the pull down. (D) Summary of the interactions between Mlc1p derivatives and its binding partners. (E) Position of the *mlc1-11* and *mlc1-93* mutations on the three-dimensional structure of the IQ2 (from Myo2p)--Mlc1p complex ([@bib42]).](200401040f8){#fig8}

In summary, mlc1-11p is defective in its interaction with Myo2p and Iqg1p; and both mlc1-11p and mlc1-93p display a reduced interaction with Myo1p ([Fig. 8](#fig8){ref-type="fig"} D). The fact that both mutant proteins localized normally to the bud neck suggests that the mechanism underlying the septin-dependent neck localization of Mlc1p is still largely intact and that mlc1-11p is unable to recruit or maintain Iqg1p at the neck. Consistent with this separation of functions for Mlc1p is the observation that a mutation at the corresponding position as *mlc1-11* in Cdc4p, the ELC for type II myosins in *S. pombe*, also causes a temperature-sensitive cytokinesis defect without affecting the overall conformation of the protein ([@bib40]). Because *mlc1-93* cells did not show any obvious defect in cytokinesis in an otherwise wild-type background, these results lend further support to our previous notion that the Myo1p--Mlc1p interaction may not play a major role in regulating Myo1p function or cytokinesis. Because elimination of the Mlc1p--Myo2p interaction by deletion of the IQ motifs of Myo2p ([@bib41]) also does not cause any obvious defect in cytokinesis, the phenotype of *mlc1-11* cells suggests that the cytokinesis defect is mainly due to its defective interaction with Iqg1p or due to a combinatorial effect of its decreased interactions with all the binding partners. Strikingly, the *mlc1-11* mutation ([Fig. 8](#fig8){ref-type="fig"} E, green) mapped on the three-dimensional structure of IQ2 (from Myo2p)-Mlc1p complex ([@bib42]) at the interface between the IQ motif and the COOH-terminal domain of Mlc1p, whereas the *mlc1-93* mutation ([Fig. 8](#fig8){ref-type="fig"} E, red) was mapped at a site quite distal to the IQ2-Mlc1p interface. Previous data has demonstrated that alleles of *CDC4* in *S. pombe* display intragenic complementation ([@bib29]). Our data, taken with the structural studies ([@bib40]; [@bib42]) suggest that Mlc1p interactions with the IQ regions of Myo1p and Myo2p and/or Iqg1p may be mediated, at least in part, through distinct domains and thereby explains the intragenic complementation of some ELC alleles.

Discussion
==========

Mlc2p regulates the disassembly of the Myo1p ring
-------------------------------------------------

We have shown that Mlc2p shares a localization and contraction profile in the cell cycle with Myo1p and that the neck localization of Mlc2p completely depends on Myo1p. In addition, coIP and localization experiments indicate that Mlc2p binds to Myo1p exclusively through the IQ2 motif of Myo1p; thus defining Mlc2p as the RLC for Myo1p.

Deletion of *MLC2* produced a mild but consistent defect in the disassembly of the Myo1p ring, at least at the end of its contraction. Because the Myo1p ring is small, even in tetraploid cells, we cannot rule out the possibility that there also might be a subtle change in the contraction kinetics in *mlc2*Δ cells that we could not detect. In fact, a defect in contraction could certainly arise from a defect in disassembly because these processes are normally coupled ([@bib34]). The biochemical basis for the Myo1p disassembly defect is not clear. However, the type II myosin purified from *D. discoideum* RLC null cells formed thick filaments comparable to wild-type myosin, but displayed a defect in the disassembly properties in vitro ([@bib7]). These data suggest that the basic function of an RLC may be conserved through evolution. Further biochemical studies on different pairs of RLC--heavy chain interactions are required to determine whether or not a common molecular mechanism underlies the similar function for the RLCs.

The family of RLCs for nonmuscle type II myosins appears to have three features. First, they share very limited sequence homology. For example, Mlc2p displays only 19% identity and 38% similarity in amino acid sequence with Rlc1p, the RLC in *S. pombe*. Second, the requirement for the function of the RLC in modulating the heavy-chain activity and thus in cytokinesis appears to increase with organismal complexity. In *Drosophila melanogaster*, mutations in the RLC gene *spaghetti-squash* cause embryonic lethality and a severe defect in cytokinesis ([@bib19]). In *D. discoideum*, deletion of the RLC gene does not cause cell lethality, but produces a cytokinesis defect similar to that caused by deletion of the heavy chain ([@bib7]). In *S. pombe*, *rlc1* is only needed for cell viability and cytokinesis at low temperature ([@bib21]; [@bib28]). In *S. cerevisiae*, deletion of *MLC2* produces a mild defect in the disassembly of the Myo1p ring that is only detectable with a sensitive approach such as time-lapse microscopy. Finally, RLCs appear to act on their respective type II myosins only, which may explain why these light chains are so evolutionarily divergent.

Mlc1p may interact with Myo1p, Iqg1p, and Myo2p to coordinate the formation and contraction of the actomyosin ring with targeted membrane deposition
----------------------------------------------------------------------------------------------------------------------------------------------------

We show here that Mlc1p binds to Myo1p through the IQ1 motif of Myo1p, suggesting that Mlc1p is an ELC for Myo1p. Mlc1p is also a light chain for Myo2p (the type V myosin) and Iqg1p (IQGAP; [@bib41]; [@bib36]). It is not clear how Mlc1p interacts with different proteins in a temporally and spatially regulated manner to carry out its essential function in cytokinesis. The relative contribution of each Mlc1p interaction to its role in cytokinesis can be assessed by analyzing the consequences of disrupting each specific interaction by mutations in Mlc1p or its binding partners.

First, the Mlc1p--Myo1p interaction does not appear to play a significant role in regulating Myo1p function, because deletion of IQ1 alone or together with IQ2 in Myo1p, which abolished the binding of Mlc1p to Myo1p, did not cause an obvious defect in cytokinesis. The phenotype of *myo1-(IQ1*Δ+*IQ2*Δ*)* is much less severe than complete deletion of *MYO1* in this strain background, suggesting that Myo1p can perform some functions in cytokinesis in the absence of Mlc1p binding. This conclusion is further supported by the fact that a specific mutation in *MLC1* (*mlc1-93*) that decreased the Mlc1p--Myo1p interaction, but maintained the Mlc1p--Iqg1p and the Mlc1p--Myo2p interactions, did not show any obvious defect in cytokinesis either. Second, the Mlc1p--Myo2p interaction is not responsible for the major role of Mlc1p in cytokinesis because a *myo2-IQ6*Δ strain, in which Mlc1p does not interact with Myo2p directly ([@bib41]), is able to carry out cytokinesis to a large degree, although it may be slightly defective in cytokinesis and/or cell separation. Even simultaneous disruption of the Mlc1p--Myo1p and the Mlc1p--Myo2p interactions in a *myo1-(IQ1*Δ+*IQ2*Δ*) myo2-IQ6*Δ strain did not cause a defect in cytokinesis nearly as severe as the depletion of Mlc1p, although the double mutant showed a slight additive defect in cytokinesis (unpublished data). These data suggest that the interaction of Mlc1p with Myo1p and Myo2p plays a somewhat minor role in cytokinesis.

In contrast, the Mlc1p--Iqg1p interaction appears to play a major role in cytokinesis. A specific mutation in *MLC1* (*mlc1-11*), which causes a defect in its interactions with Myo1p, Myo2p, and Iqg1p, is defective in cytokinesis. Because the Mlc1p--Myo1p and Mlc1p--Myo2p interactions play only a fine-tuning role in cytokinesis, the major role of Mlc1p in cytokinesis is likely performed through its interaction with Iqg1p. Mlc1p is required for the recruitment of Iqg1p to the bud neck ([@bib4]; [@bib36]), which, in turn, is required for actin ring formation ([@bib11]; [@bib22]); thus, Mlc1p--Iqg1p interaction plays an essential role in the assembly of the actomyosin ring. Both Mlc1p and Iqg1p must play an additional role in cytokinesis independent of their role in actomyosin ring assembly because deletion of *MLC1* or *IQG1* causes cell lethality with cells accumulating in chains, whereas deletion of *MYO1*, which abolishes the actomyosin ring function ([@bib3]), in the same strain background does not ([@bib4]; unpublished data). Indeed, multicopy *HOF1* or *CYK3* can suppress an *iqg1* deletion and its associated cytokinesis defect without restoring the actomyosin ring function ([@bib20]). The actomyosin ring-independent function of Iqg1p in cytokinesis could involve targeted secretion to the bud neck and/or septum formation ([@bib20]; [@bib1]; [@bib30]).

In contrast to RLCs, the sequences and functions of the ELCs of the type II myosins appear to be better conserved through evolution. For example, Mlc1p shares 42% identity and 61% similarity in amino acid sequence with Cdc4p, the ELC of type II myosins in *S. pombe*. In addition, all known ELCs including Cdc4p in *S. pombe*, Mlc1p in *S. cerevisiae*, and ELC in *D. discoideum* play an essential role or as important a role as their respective heavy chains in cytokinesis ([@bib32]; [@bib27]; [@bib41]; [@bib10]). Like Mlc1p, Cdc4p in *S. pombe* also appears to interact with the IQGAP and a type V myosin to execute its function in cytokinesis ([@bib10]; [@bib51]). The interactions of the ELCs with other conserved molecules may act as an evolutionary constraint and explain the higher conservation among the ELCs from different organisms.

An integrated view of cytokinesis in *S. cerevisiae*
----------------------------------------------------

Increasing evidence suggests that cytokinesis in animal cells and in fungi involves interplay between actomyosin ring function and targeted secretion to the division site ([@bib16]; [@bib38]; [@bib50]). In *S. cerevisiae*, cytokinesis involves the coordinated action of the actomyosin ring and septum formation ([Fig. 9](#fig9){ref-type="fig"} A), which probably requires targeted secretion ([@bib48]; [@bib1]; [@bib33]). The function of the actomyosin ring might be to guide septum formation by targeting secretion to the precise location at the precise time ([@bib48]; [@bib1]). At the molecular level ([Fig. 9](#fig9){ref-type="fig"} B), septins, a family of GTP-binding, filament-forming proteins in eukaryotes ([@bib14]; [@bib24]), form a collar at the bud neck that provides an anchoring site for the actomyosin ring components such as Myo1p and proteins involved in septum formation such as Chs2p, Bni4p, Chs3p, Chs4p, and Mlc1p ([@bib37]; [@bib8]; [@bib3]; [@bib22]; [@bib36]; [@bib33]; [@bib49]). Mlc1p interacts with both Myo1p and Iqg1p to promote the formation of a functional actomyosin ring. Mlc2p may regulate the disassembly of the Myo1p ring during and/or at the end of its contraction. In contrast, Mlc1p also interacts with Myo2p and perhaps Iqg1p to promote targeted membrane deposition at the bud neck. Through these interactions, Mlc1p may effectively coordinate targeted secretion with the actomyosin ring. This coordination mechanism may ensure the maximal efficiency of the cytokinesis process.

![**An integrated view of cytokinesis in *S. cerevisiae*.** (A) Cytokinesis in *S. cerevisiae*. Both the actomyosin ring (Myo1p ring in green and actin ring in red) and the secretory machinery (vesicles in black and motors in purple) are targeted to the bud neck in a septin (blue)-dependent manner in late anaphase of the cell cycle to promote efficient cytokinesis. (B) Coordinating different elements of cytokinesis through the ELC Mlc1p. Mlc1p interacts with Myo1p and Iqg1p to promote actomyosin ring formation at the bud neck. Mlc1p interacts with Myo2p and Iqg1p to promote targeted membrane deposition at the bud neck. Mlc2p affects the disassembly of the Myo1p ring during and/or after the ring contraction.](200401040f9){#fig9}

The role of the ELC in promoting actomyosin ring formation through type II myosin and IQGAP and in coordinating the actomyosin ring contraction with targeted secretion through type V myosin, and perhaps IQGAP, appears to be a conserved feature in cytokinesis between *S. cerevisiae* and *S. pombe*, two distantly related fungi, although many details of biochemical interactions require further investigation. Because all the major molecules involved in these processes are conserved through evolution, it is tempting to speculate that similar mechanisms involving the ELC may exist in animal cells.

Materials and methods
=====================

Strains, growth conditions, and genetic methods
-----------------------------------------------

Yeast strains are listed in [Table I](#tbl1){ref-type="table"}. Standard culture media and genetic methods were used ([@bib15]). In some cases, 1 mg/ml 5-fluoroorotic acid (Angus Buffers & Biochemicals) was added to media to select for loss of *URA3*-containing plasmids.

###### Yeast strains used in this study

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Strain        Genotype                                                                                                  Reference or source
  ------------- --------------------------------------------------------------------------------------------------------- --------------------------------------------
  JGY28B        **a** *sec2-41 his3 leu2 trp1 ura3*                                                                       [@bib12]

  M-17          **a** *cdc12-6 leu2 ura3*                                                                                 [@bib6]

  PJ69-4α       α *trp1-901 leu2-3,112 ura3-52 his3-200 gal4*Δ *gal80*Δ *LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ*       [@bib17]

  PJ69-4**a**   **a** *trp1-901 leu2-3,112 ura3-52 his3-200 gal4*Δ *gal80*Δ *LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ*   [@bib17]

  RSY21         **a** *myo2IQ6*Δ *ade2 can1-100 his3 leu2 trp1 ura3*                                                      [@bib41]

  RSY22         α *myo2IQ6*Δ *ade2 can1-100 his3 leu2 trp1 ura3*                                                          [@bib41]

  SEY6210       α *his3 leu2 lys2 suc2 trp1 ura3*                                                                         [@bib5]

  SEY5188       α *sec18-1 leu2 suc2 ura3*                                                                                [@bib5]

  SSC1          **a** *ade2-1 ura3-52 his3 leu2-3, 112, trp1-1 can1-100*                                                  [@bib4]

  SSC349        **a** *myo1*Δ*::URA3 MLC1:3HA-TRP1 ade2-1 ura3-52 his3 leu2-3, 112, trp1-1 can1-100*                      [@bib4]

  SSC350        **a** *myo1*Δ*::URA3 IQG1:3HA-TRP1 ade2-1 ura3-52 his3 leu2-3, 112, trp1-1 can1-100*                      [@bib4]

  Y3656         α *can1*Δ*::MFA1pr-HIS3-Mfa1pr-LEU2*                                                                      [@bib44]

  YEF473        **a**/α *his3/his3 leu2/leu2 lys2/lys2 trp1/trp1 ura3/ura3*                                               [@bib2]

  YEF473A       **a** *his3 leu2 lys2 trp1 ura3*                                                                          [@bib2]

  YEF1804       **a** *myo1*Δ*::Kan his3 leu2 lys2 trp1 ura3*                                                             [@bib3]

  YEF1820       As YEF473 except *myo1*Δ*::Kan/myo1*Δ*::HIS3*                                                             [@bib3]

  YEF2056       **a** *myo1*Δ*::HIS3 his3 leu2 lys2 trp1 ura3* (YCp50-MYO1)                                               This study[a](#tfn1){ref-type="table-fn"}

  YEF2293       **a** *MYO1:GFP-Kan his3 leu2 lys2 trp1 ura3*                                                             See text

  YEF2294       α *MYO1:GFP-Kan his3 leu2 lys2 trp1 ura3*                                                                 See text

  YEF2311       As YEF473 except *MYO1:GFP-Kan/ MYO1:GFP-Kan*                                                             YEF2293 X\
                                                                                                                          YEF2294

  YEF2455       As YEF473 except *MLC2::GFP-Kan/MLC2*                                                                     See text

  YEF2473       α *MLC2:GFP-Kan his3 leu2 lys2 trp1 ura3*                                                                 Segregant of YEF2455

  YEF2565       As YEF473 except *myo1*Δ*::HIS3/myo1*Δ*::HIS3 MLC2:GFP-Kan/MLC2:GFP-Kan* (YCp50-MYO1)                     This study[b](#tfn2){ref-type="table-fn"}

  YEF2598       As YEF473 except *mlc2*Δ*::HIS3/MLC2*                                                                     See text

  YEF2603       As YEF473 except *myo1*Δ*::HIS3/myo1*Δ*::HIS3 MLC2:GFP-Kan/MLC2:GFP-Kan*                                  This study[c](#tfn3){ref-type="table-fn"}

  YEF2612       **a** *mlc2*Δ*::HIS3 MYO1:GFP-Kan his3 leu2 lys2 trp1 ura3*                                               This study[d](#tfn4){ref-type="table-fn"}

  YEF2616       As YEF473 except *mlc2D::HIS3/mlc2D::HIS3 MYO1:GFP-Kan/ MYO1:GFP-Kan*                                     This study[d](#tfn4){ref-type="table-fn"}

  YEF2661       As YEF473 except *MLC2:MYC-HIS3/MLC2*                                                                     See text

  YEF3175       **a** *myo1*Δ*::Kan MLC2:GFP-HIS3 his3 leu2 lys2 trp1 ura3*                                               This study[e](#tfn5){ref-type="table-fn"}

  YEF3176       **a** *myo1*Δ*::Kan MLC1:3HA-TRP1 ade2-1 ura3-52 his3 leu2-3, 112, trp1-1 can1-100*                       This study[f](#tfn6){ref-type="table-fn"}

  YEF3233       YEF1820 (pRS316-N-MYO1-GFP)                                                                               This study

  YEF3235       YEF1820 (pRS316-MYO1-IQ2Δ-GFP)                                                                            This study

  YEF3302       **a** *mlc2*Δ*::TRP1 MYO1:GFP-Kan his3 leu2 lys2 trp1 ura3*                                               This study[g](#tfn7){ref-type="table-fn"}

  YEF3303       α *mlc2*Δ*::TRP1 MYO1:GFP-Kan his3 leu2 lys2 trp1 ura3*                                                   This study[g](#tfn7){ref-type="table-fn"}

  YEF3323       **aa**/αα (*MYO1:GFP-Kan*)×4(*can1*Δ*::MFA1pr-HIS3-Mfa1pr-LEU2*)×2 (*his3 leu2 lys2 trp1 ura3*)×4         See text

  YEF3324       As YEF3323 except *(mlc2*Δ*::TRP1)*×4                                                                     See text

  YEF3380       **a** *myo2IQ6*Δ *myo1*Δ*::Kan ade2 can1-100 his3 leu2 trp1 ura3*                                         This study[h](#tfn8){ref-type="table-fn"}

  Y5005-8D      **a** *mlc1-11 his3 leu2 lys2 trp1 ura3*                                                                  This study[i](#tfn9){ref-type="table-fn"}

  Y5119-20A     **a** *mlc1-93 his3 leu2 lys2 trp1 ura3*                                                                  This study[i](#tfn9){ref-type="table-fn"}

  YJL114A       **a** *myo2IQ6*Δ *myo1*Δ*::NatR myo4*Δ*::Kan ade2 can1-100 his3 leu2 trp1 ura3*                           This study[j](#tfn10){ref-type="table-fn"}

  YJL126        **a** *myo4*Δ*::Kan ade2-1 ura3-52 his3 leu2-3, 112, trp1-1 can1-100*                                     This study[k](#tfn11){ref-type="table-fn"}

  YJL175A       **a** *myo1*Δ*::URA3 IQG1:3HA-TRP1 MYO2:MYC-Kan ade2-1 ura3-52 his3 leu2-3, 112, trp1-1 can1-100*         See text

  YJL176A       **a** *MYO1:HA-TRP1 MYO2:MYC-Kan his3 leu2 lys2 trp1 ura3*                                                See text
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------

YEF1751 (*myo1*Δ*::HIS3/MYO1*) carrying YCp50-MYO1 ([@bib48]) was sporulated to generate YEF2056.

YEF2056 was crossed to YEF2473. Segregants with appropriate genotypes and opposite mating types were crossed to form YEF2565.

YEF2603 was obtained after curing YCp50-MYO1 from YEF2565 through 5FOA selection.

A PCR fragment carrying *mlc2*Δ*::HIS3* was amplified from YEF2598 and transformed into YEF2293 and YEF2294, yielding YEF2612 and YEF2613, respectively, which were then crossed to generate YEF2616.

A PCR fragment carrying *myo1*Δ*::Kan* was amplified from YEF1804 and transformed into a segregant of YEF2661 to generate YEF3175.

A PCR fragment carrying *myo1*Δ*::Kan* was amplified from YEF1804 and transformed into SSC349, selecting for Kan^r^ Ura^−^ to generate YEF3176.

Constructed by transforming a PCR fragment carrying *mlc2*Δ*::TRP1*, generated as described previously ([@bib25]), into YEF2612, selecting for Trp^+^ His^−^ colonies.

RSY21 carrying YEplac181 (2 μm *LEU2*; [@bib13]) was crossed to RSY22 carrying pRS316 (*CEN URA3*; [@bib39]) to generate YEF3291. After curing both plasmids, the resulting diploid was transformed with a PCR fragment carrying *myo1*Δ*::Kan* amplified from YEF1804, generating YEF3304, sporulation of which gave rise to YEF3380.

Segregants from the second backcrosses between the *mlc1* mutants (from the *hof1*Δ synthetic-lethal screen) and the wild-type strain YEF473A.

The *myo1*Δ*::Kan* in YEF3380 was converted to *myo1*Δ*::NatR* through homologous recombination (the *NatR*-carrying plasmid was provided by C. Boone). The resulting strain was then transformed with a PCR-amplified fragment carrying *myo4*Δ*::Kan*, generating strain YJL114A. The template for the PCR was the chromosomal DNA from a *myo4*Δ*::Kan* strain, which was provided by C. Burd (University of Pennsylvania School of Medicine, Philadelphia, PA).

A PCR-amplified fragment carrying *myo4*Δ*::Kan* was generated as in j and then transformed into SCC1 to yield YJL126.

Plasmids
--------

Plasmid pOBD-MYO1-N was constructed by cloning the Myo1p-head (amino acids 1--855) coding sequence into pOBD by a gap repair-mediated method ([@bib9]). Plasmids pOAD carrying different light chain-related genes used in [Fig. 1](#fig1){ref-type="fig"} B were supplied by S. Fields\' group (University of Washington, Seattle, WA). Plasmid YCp50-MYO1 (*CEN URA3*; supplied by S. Brown, University of Michigan, Ann Arbor, MI) carries wild-type *MYO1* under its own promoter control. Plasmid pRS316NoNot is a derivative of pRS316 (*CEN URA3*; [@bib39]), in which the unique NotI site has been destroyed ([@bib6]). Plasmid pRS316-MYO1 carries wild-type *MYO1* ([@bib6]). Plasmid pRS316-N-MYO1-GFP carries *MYO1* with a *GFP* cassette inserted in-fame after the start codon of *MYO1* ([@bib6]). Different IQ mutations (R806A, IQ1Δ, IQ2Δ, and IQ1Δ+IQ2Δ) of *MYO1* were introduced into pRS316-N-MYO1-GFP using a PCR-based method with appropriate mutagenic primers. Plasmid pRS315-GFP-RAS2 contains an ∼2.5-kb HindIII-XbaI fragment carrying *GFP-RAS2* from plasmid pIW192 ([@bib31]) that was cloned into the corresponding sites in pRS315 (*CEN LEU2*; [@bib39]). Plasmids pUG34-MLC1 (*CEN HIS3*) and pUG35-IQG1 (*CEN URA3*; supplied by A. Ragnini-Wilson, University of "Tor Vergata" Rome, Rome, Italy) carrying *MET25p-yEGFP-MLC1* and *MET25p-yEGFP-IQG1*, respectively, were described previously ([@bib49]). Plasmid pUG34 (supplied by J.H. Hedgemann, Heinrich-Heine-Universität, Düsseldorf, Germany) carrying *mlc1-11* or *mlc-93* was constructed similarly as pUG34-MLC1. A PCR fragment flanking the *MLC1* locus was amplified from the mutant strain carrying *mlc1-11* or *mlc1-93*. PCR fragments were mixed with XmaI-EcoRI--digested pUG34 and transformed into YEF473A for gap-repair to generate the desired plasmids. All mutants were confirmed by DNA sequencing at the Sequencing Facility of the University of Pennsylvania. All oligonucleotide primers were purchased from Integrated DNA technologies.

Construction of yeast strains
-----------------------------

Strains carrying *MYO1:GFP-Kan* (YEF2293 and YEF2294), *MLC2:GFP-Kan* (YEF2455), *MLC2:MYC-HIS3* (YEF2661,) and *mlc2*Δ*::HIS3* (YEF2598) were constructed using a PCR-based method ([@bib25]), except that the *gfp* allele in the template plasmid pFA6a-GFP (S65T, F64L)-KanMX6 carries two mutations ([@bib6]). Strains YJL175A (*IQG1:3HA-TRP1 MYO2:MYC-Kan*) and YJL176A (*MYO1:3HA-TRP1 MYO2:MYC-Kan*) were constructed by introducing an affinity-tagged allele of *MYO1* and *MYO2* by a PCR-based method ([@bib25]) into strains SSC350 and YEF473A, respectively.

To construct the tetraploid strains, an ∼3.9-kb PCR fragment carrying the dual reporter *can1*Δ*::MFA1pr-HIS3-Mf*α*1pr-LEU2* was amplified from strain Y3656 (supplied by C. Boone, University of Toronto, Toronto, Canada) and transformed intoYEF2293 (**a** *MYO1:GFP-Kan*) and YEF3302 (**a** *mlc2*Δ*::TRP1 MYO1:GFP-Kan*), selecting for His^+^, Canavanine-resistant colonies, to generate YEF3305 and YEF3306, respectively. These two strains were crossed with YEF2294 and YEF3303, respectively, to form **a**/α strains YEF3316 and YEF3317 that are heterozygous for the dual reporter locus. YEF3316 and YEF3317 were streaked onto SC-His and SC-Leu plates, respectively, to generate **aa** and αα versions of strains carrying *MYO1:GFP-Kan* (YEF3318 and YEF3319) or *mlc2*Δ*::TRP1 MYO1:GFP-Kan* (YEF3320 and YEF3321). The mating types were confirmed by monitoring pheromone secretion. YEF3318 and YEF3319 or YEF3320 and YEF3321 were crossed to generate the tetraploid YEF3323 or YEF3324, which was confirmed by sporulation.

CoIP
----

50 OD~600~ of yeast cells grown exponentially in SC-Ura media were disrupted with glass beads by vortexing at 4°C in 500 μl of 1× PBS buffer, containing 0.1% NP-40 and a mixture of protease inhibitors. After centrifugation to remove cell debris, the supernatant was used for immunoprecipitation with 100 μl of slurry of agarose beads conjugated with either anti-HA mAb or anti-MYC mAb (Covance Research Products Inc.). After incubation at 4°C for 12--16 h, beads were washed five times with lysis buffer, and proteins bound to the beads were eluted with SDS sample buffer. The precipitated Mlc2p-Myc or Mlc1p-HA, the total Myo1p-GFP variants in supernatants, and the bound fractions of Myo1p-GFP variants to the anti-MYC or anti-HA beads were separated by SDS-PAGE and blotted with anti-MYC, anti-HA, and anti-GFP mAbs, respectively (Covance Research Products Inc.). The secondary antibodies were peroxidase-conjugated goat anti--mouse IgG (Jackson ImmunoResearch Laboratories).

Microscopy
----------

Cell morphologies and GFP-tagged proteins were visualized by differential interference contrast (DIC) and fluorescence microscopy, respectively. DNA was stained with 1 μg/ml bisBenzimide (Sigma-Aldrich).

For time-lapse microscopy, cells growing exponentially in liquid SC-Ura medium were spotted onto a microscope slide spread with a thin layer of SC-Ura medium solidified with 25% gelatin ([@bib52]). Individual cells were followed at 1- or 2-min intervals using a computer-controlled microscope (model Eclipse E800; Nikon) with motorized focus and a high-resolution CCD camera (model C4742-95; Hamamatsu Photonics). For each time point, one DIC image and one GFP image were acquired and analyzed using Image-Pro Plus software (Media Cybernetics). The contrast of the images was enhanced using Image-Pro Plus and/or Adobe PhotoShop Version 7.0 (Adobe Systems). For time-lapse microscopy at 37°C, the objective lens was heated and maintained at 37°C using an objective heater (Bioptechs) during the course of the experiments. The rate of Myo1p ring contraction was determined as follows: the diameter of Myo1p ring before shrinkage minus the diameter of the first Myo1p dot divided by the time required to undergo this change in diameter.
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